These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25363549)

  • 21. Association of exudative age-related macular degeneration with matrix metalloproteinases-2 (-1306 C/T) rs243865 gene polymorphism.
    Liutkeviciene R; Vilkeviciute A; Borisovaite D; Miniauskiene G
    Indian J Ophthalmol; 2018 Apr; 66(4):551-557. PubMed ID: 29582818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene-gene interactions of CFH and LOC387715/ARMS2 with Korean exudative age-related macular degeneration patients.
    Kim YH; Kim HS; Mok JW; Joo CK
    Ophthalmic Genet; 2013 Sep; 34(3):151-9. PubMed ID: 23289807
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of the CFH Y402H Polymorphism with the 1-Year Response of Exudative AMD to Intravitreal Anti-VEGF Treatment in the Brazilian Population.
    Medina FMC; Motta AALD; Takahashi WY; Carricondo PC; Motta MMDS; Melo MB; Vasconcellos JPC
    Ophthalmic Res; 2019; 61(3):168-173. PubMed ID: 28641277
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of CFH Y402H polymorphism with both forms of advanced age-related macular degeneration in Turkish patients.
    Yücel D; Yılmaz M; Durukan AH; Özgül RK
    Ophthalmic Genet; 2012 Sep; 33(3):144-9. PubMed ID: 22486323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study.
    Klein R; Myers CE; Cruickshanks KJ; Gangnon RE; Danforth LG; Sivakumaran TA; Iyengar SK; Tsai MY; Klein BE
    JAMA Ophthalmol; 2014 Apr; 132(4):446-55. PubMed ID: 24481424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C-reactive protein levels and complement factor H polymorphism interaction in age-related macular degeneration and its progression.
    Robman L; Baird PN; Dimitrov PN; Richardson AJ; Guymer RH
    Ophthalmology; 2010 Oct; 117(10):1982-8. PubMed ID: 20605213
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interaction of susceptibility genes in patients with exudative age-related macular degeneration].
    Liang X; Cui L; Gu H; Zhou HY; Xu J; Liu NP
    Zhonghua Yan Ke Za Zhi; 2012 Mar; 48(3):241-5. PubMed ID: 22800422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between systemic cytokines and complement factor H Y402H polymorphism in patients with dry age-related macular degeneration.
    Cao S; Ko A; Partanen M; Pakzad-Vaezi K; Merkur AB; Albiani DA; Kirker AW; Wang A; Cui JZ; Forooghian F; Matsubara JA
    Am J Ophthalmol; 2013 Dec; 156(6):1176-83. PubMed ID: 24083687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ARMS2 A69S Polymorphism Is Associated with Delayed Rod-Mediated Dark Adaptation in Eyes at Risk for Incident Age-Related Macular Degeneration.
    Mullins RF; McGwin G; Searcey K; Clark ME; Kennedy EL; Curcio CA; Stone EM; Owsley C
    Ophthalmology; 2019 Apr; 126(4):591-600. PubMed ID: 30389424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration.
    Despriet DD; Klaver CC; Witteman JC; Bergen AA; Kardys I; de Maat MP; Boekhoorn SS; Vingerling JR; Hofman A; Oostra BA; Uitterlinden AG; Stijnen T; van Duijn CM; de Jong PT
    JAMA; 2006 Jul; 296(3):301-9. PubMed ID: 16849663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CFH Y402H polymorphism is associated with elevated vitreal GM-CSF and choroidal macrophages in the postmortem human eye.
    Wang JC; Cao S; Wang A; To E; Law G; Gao J; Zhang D; Cui JZ; Matsubara JA
    Mol Vis; 2015; 21():264-72. PubMed ID: 25814824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Smoking and CFH and ARMS2 Risk Variants With Younger Age at Onset of Neovascular Age-Related Macular Degeneration.
    Lechanteur YT; van de Camp PL; Smailhodzic D; van de Ven JP; Buitendijk GH; Klaver CC; Groenewoud JM; den Hollander AI; Hoyng CB; Klevering BJ
    JAMA Ophthalmol; 2015 May; 133(5):533-41. PubMed ID: 25695752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between vitamin D status and age-related macular degeneration by genetic risk.
    Millen AE; Meyers KJ; Liu Z; Engelman CD; Wallace RB; LeBlanc ES; Tinker LF; Iyengar SK; Robinson JG; Sarto GE; Mares JA
    JAMA Ophthalmol; 2015 Oct; 133(10):1171-9. PubMed ID: 26312598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Joint association of complement component 3 and CC-cytokine ligand2 (CCL2) or complement component 3 and CFH polymorphisms in age-related macular degeneration.
    Bonyadi M; Jabbarpoor Bonyadi MH; Yaseri M; Mohammadian T; Fotouhi N; Javadzadeh A; Soheilian M
    Ophthalmic Genet; 2017; 38(4):365-370. PubMed ID: 28095095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of genetic base in the treatment of age-related macular degeneration.
    Gourgouli K; Gourgouli I; Tsaousis G; Spai S; Niskopoulou M; Efthimiopoulos S; Lamnissou K
    Int Ophthalmol; 2020 Apr; 40(4):985-997. PubMed ID: 31916060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coding and noncoding variants in the CFH gene and cigarette smoking influence the risk of age-related macular degeneration in a Japanese population.
    Mori K; Gehlbach PL; Kabasawa S; Kawasaki I; Oosaki M; Iizuka H; Katayama S; Awata T; Yoneya S
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5315-9. PubMed ID: 17962488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined effects of genetic and non-genetic risk factors affect response to ranibizumab in exudative age-related macular degeneration.
    Piermarocchi S; Miotto S; Colavito D; Leon A; Segato T
    Acta Ophthalmol; 2015 Sep; 93(6):e451-7. PubMed ID: 25402348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genes in the high-density lipoprotein metabolic pathway in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Liu K; Chen LJ; Lai TY; Tam PO; Ho M; Chiang SW; Liu DT; Young AL; Yang Z; Pang CP
    Ophthalmology; 2014 Apr; 121(4):911-6. PubMed ID: 24393350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare Genetic Variants Associated With Development of Age-Related Macular Degeneration.
    Saksens NT; Geerlings MJ; Bakker B; Schick T; Daha MR; Fauser S; Boon CJ; de Jong EK; Hoyng CB; den Hollander AI
    JAMA Ophthalmol; 2016 Mar; 134(3):287-93. PubMed ID: 26767664
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine Profiling in Patients With Exudative Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Agrawal R; Balne PK; Wei X; Bijin VA; Lee B; Ghosh A; Narayanan R; Agrawal M; Connolly J
    Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):376-382. PubMed ID: 30682207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.